Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01876511
Title Phase 2 Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

Advanced Solid Tumor

colorectal cancer

Therapies

Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Stanford California 94305 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231 United States Details
Investigator Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, NIH Bethesda Maryland 20892 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
University of Pennsylvania, Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
University of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field